CryoCor (CRYO) Misses Q4 EPS by 2c
More News related to CRYO
- Unusual 11 Mid-Day Movers 4/16: POZN, SORC, EXM, GRO Higher; TLB, HCSG, GLG, CDL Lower
- Notable Mergers and Acquisitions of the Day 4/16 (XRX/CXP, FITB/FCTR, BSX/CRYO)
- Boston Scientific To Acquire CryoCor (CYRO) for $1.35/Share
- CryoCor (CRYO) Receives 'Going Concern' From Auditor, Nasdaq Reviews Listing Eligibility
- CryoCor (CRYO) Misses Q4 EPS by 2c
More News related to Earnings
- Top 10 News Items 11/23-11/27: Dubai Debt Fallout; Gold; GDP Revised Lower; Diedrich Coffee Bidding War
- Trading Radar for 11/30: Inergy Holdings (NRGP), Golar (GLNG), Omnivision (OVTI), Knightsbridge (VLCCF) Report
- Notable Mergers and Acquisitions of the Day for 11/27: F, S/IPCS, STAR/CSCO, HRAY
- Notable Analyst Rating Changes 11/27: TIF, QLTI Upgraded; FSNM, RGFC Downgraded
- Notable ETF Movers *Special Dubai World Edition* 11/27: UUP Higher; GAF, EEM, FXI, XLF Lower
CryoCor, Inc. (Nasdaq: CRYO) reports a Q4 loss of $0.35, 2 cents worse than estimates. Revenues were $240K vs. $300K consensus.
CryoCor, Inc. has developed and manufactured a minimally invasive system based on its cryoablation technology for the treatment of cardiac arrhythmias.[SM]
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
